Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
APPswe as a risk factor for osteoporosis
Training To Provide the Knowledge, Skills, and Culture To the Next Generation of Cardiovascular Scientists
Circuitry of Emotion: Integration in the Orbitofrontal Cortex
Mechanisms of Brain Tumor Chemoresistance
Partner Age Discordance and HIV Risk Behaviors in Adolescent Girls (Sexual RP)
Recently added grants:
Effects of marijuana use on inflammation and vascular injury in adults with HIV infection
Exploiting myeloma proteome remodeling to extend proteasome inhibitor efficacy
Genomic biomarkers for cutaneous T-cell Lymphoma
The function of Ubiquitin-Specific Peptidase 22 (USP22) on T regulatory cell function
Extinction Circuits Controlling Heroin Seeking
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07153-17-0-1
Application #
7574913
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Johns Hopkins University
$389,122
NIH 2007
N01 HL
Pediatric Hydroxyuera Phase III Clinical Trial
Casella, James F. /
$523,182
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant